Krečak, I., Verstovsek, S. & Lucijanić, M. (2023). Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms. Clinical advances in hematology & oncology, 21. (10), 541-548. Retrieved from https://urn.nsk.hr/urn:nbn:hr:105:537991
Krečak, Ivan, et al. "Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms." Clinical advances in hematology & oncology, vol. 21, no. 10, 2023, pp. 541-548. https://urn.nsk.hr/urn:nbn:hr:105:537991
Krečak, Ivan, Srdan Verstovsek and Marko Lucijanić. "Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms." Clinical advances in hematology & oncology 21, no. 10 (2023): 541-548. https://urn.nsk.hr/urn:nbn:hr:105:537991
Krečak, I., Verstovsek, S. and Lucijanić, M. (2023) 'Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms', Clinical advances in hematology & oncology, 21(10), pp. 541-548. Available at: https://urn.nsk.hr/urn:nbn:hr:105:537991 (Accessed 04 September 2024)
Krečak I, Verstovsek S, Lucijanić M. Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms. Clinical advances in hematology & oncology [Internet]. 2023 October [cited 2024 September 04];21(10):541-548. Available at: https://urn.nsk.hr/urn:nbn:hr:105:537991
I. Krečak, S. Verstovsek and M. Lucijanić, "Reappraisal of cardiovascular risk factors in patients with chronic myeloproliferative neoplasms", Clinical advances in hematology & oncology, vol. 21, no. 10, pp. 541-548, October 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:537991. [Accessed: 04 September 2024]